Skip to content

Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer

Phase 1 multi-center study of safety and feasibility of chemoradiotherapy using oxydol for cervical cancer - Pilot study of chemoradiotherapy using oxydol for cervical cancer

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039045
Enrollment
20
Registered
2020-01-06
Start date
2014-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Hydrogen peroxide was to be used twice a week (Monday and Thursday/Tuesday and Friday) in combination with CCRT. We inserted 3% hydrogen peroxide solution-soaked gauze into vagina firmly contact to th

Sponsors

Juntendo University Urayasu Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: we recruited patients who have cervical caner needed radio-sensitization treatment because of unfeasibility to the standard therapy. Our selection criteria are as follow: cervical cancer patient; radical CCRT purpose; impossible or refusal of brachytherapy; 20 years or older ; without hematogenous metastasis ; having a ECOG Performance Status up to 2, and no pathological limitation, without prior treatment.

Exclusion criteria

Exclusion criteria: less than 20 years old having distant metastasis

Design outcomes

Primary

MeasureTime frame
1 month after treatment completion, 1 year, 2 years overall survival, disease-free survival and progression-free survival

Secondary

MeasureTime frame
Type, severity, and ratio of adverse events that occurred up to the date of follow-up observation

Countries

Japan

Contacts

Public Contactyuko saito

Juntendo University Urayasu Hospital Department of Radiation Oncology

anyusaike@yahoo.co.jp047-353-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026